相似文献
1
Antiplatelet therapy in cardiovascular disease.
Postgrad Med J. 2004 Mar;80(941):155-64. doi: 10.1136/pgmj.2003.007062.
2
Antiplatelet agents in stroke prevention. combination therapy: present and future.
Cerebrovasc Dis. 2000;10 Suppl 5:41-8. doi: 10.1159/000047603.
3
The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines.
Minerva Cardioangiol. 2003 Oct;51(5):531-46.
4
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Tex Heart Inst J. 1997;24(2):90-6.
5
Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Cerebrovasc Dis. 2000;10 Suppl 5:34-40. doi: 10.1159/000047602.
6
Clinical aspects of platelet inhibitors and thrombus formation.
Circ Res. 2007 May 11;100(9):1261-75. doi: 10.1161/01.RES.0000264509.36234.51.
7
Antiplatelet agents in cardiology: the choice of therapy.
Ann Thorac Surg. 2000 Aug;70(2 Suppl):S3-8. doi: 10.1016/s0003-4975(00)01608-8.
8
Antiplatelet therapy in secondary stroke prevention.
Expert Opin Pharmacother. 2001 Oct;2(10):1609-13. doi: 10.1517/14656566.2.10.1609.
9
Antiplatelet agents in atherothrombotic diseases.
Hosp Med. 2004 Feb;65(2):72-5. doi: 10.12968/hosp.2004.65.2.12057.
10
Antiplatelet drugs.
Eur J Clin Invest. 1994 Feb;24 Suppl 1:46-9. doi: 10.1111/j.1365-2362.1994.tb02427.x.
引用本文的文献
1
Perspective: Collagen induced platelet activation the GPVI receptor as a primary target of colchicine in cardiovascular disease.
Front Cardiovasc Med. 2023 Jan 19;9:1104744. doi: 10.3389/fcvm.2022.1104744. eCollection 2022.
2
Use of 3D Printing for the Development of Biodegradable Antiplatelet Materials for Cardiovascular Applications.
Pharmaceuticals (Basel). 2021 Sep 11;14(9):921. doi: 10.3390/ph14090921.
3
Phenolic Bioactives as Antiplatelet Aggregation Factors: The Pivotal Ingredients in Maintaining Cardiovascular Health.
Oxid Med Cell Longev. 2021 Aug 17;2021:2195902. doi: 10.1155/2021/2195902. eCollection 2021.
4
Platelet Activation via Shear Stress Exposure Induces a Differing Pattern of Biomarkers of Activation versus Biochemical Agonists.
Thromb Haemost. 2020 May;120(5):776-792. doi: 10.1055/s-0040-1709524. Epub 2020 May 5.
5
Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.
Nutrients. 2018 Nov 21;10(11):1813. doi: 10.3390/nu10111813.
6
Marine Diterpenes: Molecular Modeling of Thrombin Inhibitors with Potential Biotechnological Application as an Antithrombotic.
Mar Drugs. 2017 Mar 20;15(3):79. doi: 10.3390/md15030079.
7
Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational Study.
Med Arch. 2015 Dec;69(6):381-3. doi: 10.5455/medarh.2015.69.381-383.
8
Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.
BMC Med. 2010 Jun 16;8:36. doi: 10.1186/1741-7015-8-36.
9
Current developments in anti-platelet therapy.
Wien Med Wochenschr. 2006 Sep;156(17-18):472-80. doi: 10.1007/s10354-006-0330-5.
本文引用的文献
1
Clopidogrel: a review of its mechanism of action.
Platelets. 1998;9(3-4):251-5. doi: 10.1080/09537109876799.
2
Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
Z Kardiol. 2003 Mar;92(3):213-8. doi: 10.1007/s00392-003-0895-6.
3
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
Platelets. 2002 Nov;13(7):407-13. doi: 10.1080/0953710021000024402.
4
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
JAMA. 2002 Nov 20;288(19):2411-20. doi: 10.1001/jama.288.19.2411.
5
6
Platelets and thrombin generation.
Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1381-9. doi: 10.1161/01.atv.0000031340.68494.34.
7
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
N Engl J Med. 2002 Mar 28;346(13):957-66. doi: 10.1056/NEJMoa013404.
8
Aspirin---the novel antiplatelet drug.
Hong Kong Med J. 1998 Dec;4(4):415-418.
9
Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.
JAMA. 2002 Feb 6;287(5):618-21. doi: 10.1001/jama.287.5.618.
10
How to get from antiplatelet to antithrombotic treatment.
Am J Ther. 2001 Nov-Dec;8(6):443-9. doi: 10.1097/00045391-200111000-00009.
Zotero 插件